Anda belum login :: 22 Jul 2025 13:04 WIB
Halaman Awal
|
Logon
Hidden
»
Administrasi
»
Detil Koleksi
Detail Koleksi
Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women
Oleh:
Lindsay, Robert
;
Gallagher, J. Christopher
;
Kagan, Risa
;
Pickar, James H.
;
Constantine, Ginger
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 92 no. 03 (Sep. 2009)
,
halaman 1045-1052 .
Topik:
Bazedoxifene
;
bone mineral density
;
conjugated estrogens
;
osteoporosis
;
tissue-selective estrogen complex
Ketersediaan
Perpustakaan FK
Nomor Panggil:
F02.K.2009.03
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Objective To evaluate the efficacy of the tissue-selective estrogen complex, bazedoxifene/conjugated estrogens (BZA/CE), for postmenopausal osteoporosis prevention. Design Multicenter, randomized, double-blind, placebo- and active-controlled, phase 3 trial (Selective estrogen Menopause And Response to Therapy [SMART]-1). Setting Outpatient clinical study. Patient(s) Women (n = 3,397) more than 5 years and 1–5 years postmenopause were enrolled in the Osteoporosis Prevention I and II Substudies, respectively. Intervention(s) Single tablets of BZA (10, 20, or 40 mg) each with CE (0.625 or 0.45 mg), raloxifene (60 mg), or a placebo taken daily for 2 years. Main Outcome Measure(s) The primary outcome for both substudies was change in bone mineral density of the lumbar spine; bone mineral density was also measured at the hip. Result(s) In both substudies, bone mineral density increased significantly more with all BZA/CE doses compared with placebo at the lumbar spine and total hip, and for most BZA/CE doses compared with raloxifene at the lumbar spine. Osteocalcin and N-telopeptide significantly decreased with all BZA/CE doses vs. placebo and most BZA/CE doses vs. raloxifene. Conclusion(s) BZA/CE combinations decreased bone turnover and bone loss in postmenopausal women at increased risk for osteoporosis.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0,015625 second(s)